An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.
/PRNewswire/ Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of.
/PRNewswire/ Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of.
MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ — Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort.